Cargando…
miR-15a-5p regulates myocardial fibrosis in atrial fibrillation by targeting Smad7
BACKGROUND: At present, there is no effective treatment for myocardial fibrosis in atrial fibrillation (AF). It is reported that miR-15a-5p is abnormally expressed in AF patients but its specific role remains unclear. This study aims to investigate the effect of miR-15a-5p in myocardial fibrosis. ME...
Autores principales: | He, Dan, Ruan, Zhong-bao, Song, Gui-xian, Chen, Ge-cai, Wang, Fei, Wang, Mei-xiang, Yuan, Mao-kun, Zhu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697763/ https://www.ncbi.nlm.nih.gov/pubmed/35036160 http://dx.doi.org/10.7717/peerj.12686 |
Ejemplares similares
-
Involvement of plasminogen activator inhibitor-1 and its related molecules in atrial fibrosis in patients with atrial fibrillation
por: Li, Qiaoqiao, et al.
Publicado: (2021) -
miR-452-3p inhibited osteoblast differentiation by targeting Smad4
por: Wu, Ming, et al.
Publicado: (2021) -
Resveratrol improves cardiac function and left ventricular fibrosis after myocardial infarction in rats by inhibiting NLRP3 inflammasome activity and the TGF-β1/SMAD2 signaling pathway
por: Jiang, Jinjin, et al.
Publicado: (2021) -
Bioinformatics prediction and experimental verification of a novel microRNA for myocardial fibrosis after myocardial infarction in rats
por: Guo, Qianqian, et al.
Publicado: (2023) -
miR-135a Regulates Atrial Fibrillation by Targeting Smad3
por: Fan, Xueting, et al.
Publicado: (2023)